Tissue engineering of skin and regenerative medicine for wound care

Abstract

ᅟ Engineering of biologic skin substitutes has progressed over time from individual applications of skin cells, or biopolymer scaffolds, to combinations of cells and scaffolds for treatment, healing, and closure of acute and chronic skin wounds. Skin substitutes may be categorized into three groups: acellular scaffolds, temporary substitutes containing allogeneic skin cells, and permanent substitutes containing autologous skin cells. Combined use of acellular dermal substitutes with permanent skin substitutes containing autologous cells has been shown to provide definitive wound closure in burns involving greater than 90% of the total body surface area. These advances have contributed to reduced morbidity and mortality from both acute and chronic wounds but, to date, have failed to replace all of the structures and functions of the skin. Among the remaining deficiencies in cellular or biologic skin substitutes are hypopigmentation, absence of stable vascular and lymphatic networks, absence of hair follicles, sebaceous and sweat glands, and incomplete innervation. Correction of these deficiencies depends on regulation of biologic pathways of embryonic and fetal development to restore the full anatomy and physiology of uninjured skin. Elucidation and integration of developmental biology into future models of biologic skin substitutes promises to restore complete anatomy and physiology, and further reduce morbidity from skin wounds and scar. This article offers a review of recent advances in skin cell thrapies and discusses the future prospects in cutaneous regeneration.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 146

1. 1.

   Finnerty CC, Capek K, Voigt C, Hundeshagen G, Cambiaso-Daniel J, Porter C, Sousse LE, El Ayadi A, Zapata-Sirvent R, Guillory A, et al. The P50 research center in perioperative sciences: how the investment by the National Institute of General Medical Sciences in Team Science has reduced post-burn mortality. J Trauma Acute Care Surg. 2017;83(3):532-542.

   Not in our library10.1097/ta.0000000000001644

2. 2.

   Warden GD, Saffle JR, Kravitz M. A two-stage technique for excision and grafting of burn wounds. J Trauma. 1982;22(2):98-103.

   Not in our library10.1097/00005373-198202000-00004

3. 3.

   Wood FM, Giles N, Stevenson A, Rea S, Fear M. Characterisation of the cell suspension harvested from the dermal epidermal junction using a ReCell(R) kit. Burns. 2012;38(1):44-51.

   Not in our library10.1016/j.burns.2011.03.001

4. 4.

   Green H, Kehinde O, Thomas J. Growth of human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci U S A. 1979;76:5665-5668.

   Not in our library10.1073/pnas.76.11.5665

5. 5.

   Boyce ST, Hansbrough JF. Biologic attachment, growth, and differentiation of cultured human epidermal keratinocytes on a graftable collagen and chondroitin-6-sulfate substrate. Surgery. 1988;103:421-431.

   Not in our library

6. 6.

   Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen. 1999;7(4):201-207.

   Not in our library10.1046/j.1524-475x.1999.00201.x

7. 7.

   Griffiths M, Ojeh N, Livingstone R, Price R, Navsaria H. Survival of Apligraf in acute human wounds. Tissue Eng. 2004;10(7-8):1180-1195.

   Not in our library10.1089/ten.2004.10.1180

8. 8.

   Centanni JM, Straseski JA, Wicks A, Hank JA, Rasmussen CA, Lokuta MA, Schurr MJ, Foster KN, Faucher LD, Caruso DM, et al. StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial. Ann Surg. 2011;253(4):672-683.

   Not in our library10.1097/sla.0b013e318210f3bd

9. 9.

   Parenteau NL, Sabolinski M, Prosky S, Nolte C, Oleson M, Kriwet K, Bilbo P. Biological and physical factors influencing the successful engraftment of a cultured human skin substitute. Biotechnol Bioeng. 1996;523:3-14.

   Not in our library10.1002/(sici)1097-0290(19961005)52:1<3::aid-bit1>3.0.co;2-p

10. 10.

    Alexander JW, MacMillan BG, Law E, Kittur DS. Treatment of severe burns with widely meshed skin autograft, and meshed skin allograft overlay. J Trauma. 1981;21(6):433-438.

    Not in our library

11. 11.

    Medina A, Riegel T, Nystad D, Tredget EE. Modified meek micrografting technique for wound coverage in extensive burn injuries. J Burn Care Res. 2016;37(5):305-313.

    Not in our library10.1097/bcr.0000000000000244

12. 12.

    Gallico Iii GG, O'Connor NE, Compton CC, Remensynder JP, Kehinde O, Green H. Cultured epithelial autografts for giant congenital nevi. Plast Reconstr Surg. 1989;84:1-9.

    Not in our library10.1097/00006534-198907000-00001

13. 13.

    Nikkhah D, Booth S, Tay S, Gilbert P, Dheansa B. Comparing outcomes of sheet grafting with 1:1 mesh grafting in patients with thermal burns: a randomized trial. Burns. 2015;41(2):257-264.

    Not in our library10.1016/j.burns.2014.07.023

14. 14.

    Compton CC, Warland G, Kratz G. Melanocytes in cultured epithelial grafts are depleted with serial subcultivation and cryopreservation: implications for clinical outcome. J Burn Care Rehabil. 1998;19(4):330-336.

    Not in our library10.1097/00004630-199807000-00011

15. 15.

    Harriger MD, Warden GD, Greenhalgh DG, Kagan RJ, Boyce ST. Pigmentation and microanatomy of skin regenerated from composite grafts of cultured cells and biopolymers applied to full-thickness burn wounds. Transplantation. 1995;59(5):702-707.

    Not in our library10.1097/00007890-199503150-00011

16. 16.

    Greenhalgh DG. A primer on pigmentation. J Burn Care Res. 2015;36(2):247-257.

    Not in our library10.1097/bcr.0000000000000224

17. 17.

    Heimbach D, Luterman A, Burke J, Cram A, Herndon D, Hunt J, Jordan M, McManus W, Solem L, Warden G, Zawacki B. Artificial dermis for major burns: a multi-center randomized clinical trial. Ann Surg. 1988;208(3):313–9.

    Not in our library10.1097/00000658-198809000-00008

18. 18.

    Atherton DD, Tang R, Jones I, Jawad M. Early excision and application of matriderm with simultaneous autologous skin grafting in facial burns. Plast Reconstr Surg. 2010;125(2):60e-61e.

    Not in our library10.1097/prs.0b013e3181c725e5

19. 19.

    Jansen LA, De CP, Guay NA, Lineaweaver WC, Shokrollahi K. The evidence base for the acellular dermal matrix AlloDerm: a systematic review. Ann Plast Surg. 2013;70(5):587-594.

    Not in our library10.1097/sap.0b013e31827a2d23

20. 20.

    Gravante G, Delogu D, Giordan N, Morano G, Montone A, Esposito G. The use of Hyalomatrix PA in the treatment of deep partial-thickness burns. J Burn Care Res. 2007;28(2):269-274.

    Not in our library10.1097/bcr.0b013e318031a236

21. 21.

    Greenwood JE, Dearman BL. Split skin graft application over an integrating, biodegradable temporizing polymer matrix: immediate and delayed. J Burn Care Res. 2012;33(1):7-19.

    Not in our library10.1097/bcr.0b013e3182372be9

22. 22.

    Greenwood JE, Wagstaff MJ, Rooke M, Caplash Y. Reconstruction of extensive calvarial exposure after major burn injury in 2 stages using a biodegradable polyurethane matrix. Eplasty. 2016;16:e17.

    Not in our library

23. 23.

    Muangman P, Deubner H, Honari S, Heimbach DM, Engrav LH, Klein MB, Gibran NS. Correlation of clinical outcome of integra application with microbiologic and pathological biopsies. J Trauma. 2006;61(5):1212-1217.

    Not in our library10.1097/01.ta.0000195982.71400.84

24. 24.

    Heimbach DM, Warden GD, Luterman A, Jordan MH, Ozobia N, Ryan CM, Voigt DW, Hickerson WL, Saffle JR, DeClement FA, et al. Multicenter postapproval clinical trial of Integra dermal regeneration template for burn treatment. J Burn Care Rehabil. 2003;24(1):42-48.

    Not in our library10.1097/00004630-200301000-00009

25. 25.

    Branski LK, Herndon DN, Pereira C, Mlcak RP, Celis MM, Lee JO, Sanford AP, Norbury WB, Zhang XJ, Jeschke MG. Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial. Crit Care Med. 2007;35(11):2615-2623.

    Not in our library10.1097/01.ccm.0000285991.36698.e2

26. 26.

    Kopp J, Magnus NE, Rubben A, Merk HF, Pallua N. Radical resection of giant congenital melanocyte nevus and reconstruction with meek-graft covered integra dermal template. Dermatol Surg. 2003;29(6):653-657.

    Not in our library10.1046/j.1524-4725.2003.29157.x

27. 27.

    Moiemen NS, Vlachou E, Staiano JJ, Thawy Y, Frame JD. Reconstructive surgery with Integra dermal regeneration template: histologic study, clinical evaluation, and current practice. Plast Reconstr Surg. 2006;117(7 Suppl):160S-174S.

    Not in our library10.1097/01.prs.0000222609.40461.68

28. 28.

    Herndon DN. Total burn care. 2012.

    Not in our library

29. 29.

    Kagan RJ, Robb EC, Plessinger RT. Human skin banking. Clin Lab Med. 2005;25(3):587-605.

    Not in our library10.1016/j.cll.2005.06.008

30. 30.

    Harris RP, Compton JB, Abstan S. Comparison of fresh, frozen, and lyophilized porcine skin as xenografts on burned patients. Burns. 1976;2:71-75.

    Not in our library10.1016/s0305-4179(76)80001-0

31. 31.

    Burkey B, Davis W, Glat PM. Porcine xenograft treatment of superficial partial-thickness burns in paediatric patients. J Wound Care. 2016;25(2):S10-S15.

    Not in our library10.12968/jowc.2016.25.sup2.s10

32. 32.

    Hermans MH. Porcine xenografts vs. (cryopreserved) allografts in the management of partial thickness burns: is there a clinical difference? Burns. 2014;40(3):408-415.

    Not in our library10.1016/j.burns.2013.08.020

33. 33.

    Schurr MJ, Foster KN, Lokuta MA, Rasmussen CA, Thomas-Virnig CL, Faucher LD, Caruso DM, len-Hoffmann BL. Clinical evaluation of NIKS-based bioengineered skin substitute tissue in complex skin defects: phase I/IIa clinical trial results. Adv Wound Care (New Rochelle). 2012;1(2):95-103.

    Not in our library10.1089/wound.2011.0343

34. 34.

    Sood R, Roggy D, Zieger M, Balledux J, Chaudhari S, Koumanis DJ, Mir HS, Cohen A, Knipe C, Gabehart K, et al. Cultured epithelial autografts for coverage of large burn wounds in eighty-eight patients: the Indiana University experience. J Burn Care Res. 2010;31(4):559-568.

    Not in our library10.1097/bcr.0b013e3181e4ca29

35. 35.

    Gravante G, Di Fede MC, Araco A, Grimaldi M, De AB, Arpino A, Cervelli V, Montone A. A randomized trial comparing ReCell system of epidermal cells delivery versus classic skin grafts for the treatment of deep partial thickness burns. Burns. 2007;33(8):966-972.

    Not in our library10.1016/j.burns.2007.04.011

36. 36.

    Duranceau L, Genest H, Bortoluzzi P, Moulin V, Auger FA, Germain L. Successful grafting of a novel autologous tissue-engineered skin substitutes (dermis and epidermis) on twelve burn patients. J Burn Care Res. 2014;35(3):S121.

    Not in our library

37. 37.

    Boyce ST, Warden GD. Principles and practices for treatment of cutaneous wounds with cultured skin substitutes. Am J Surg. 2002;183(4):445-456.

    Not in our library10.1016/s0002-9610(02)00813-9

38. 38.

    Hansbrough JF, Boyce ST, Cooper ML, Foreman TJ. Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen-glycosaminoglycan substrate. JAMA. 1989;262(15):2125-2130.

    Not in our library10.1001/jama.1989.03430150093032

39. 39.

    Boyce ST, Simpson PS, Rieman MT, Warner PM, Yakuboff KP, Kevin BJ, Nelson JK, Fowler LA, Kagan RJ. Randomized, paired-site comparison of autologous engineered skin substitutes and split-thickness skin graft for closure of extensive, full-thickness burns. J Burn Care Res. 2017;38(2):61-70.

    Not in our library10.1097/bcr.0000000000000401

40. 40.

    Desai MH, Mlakar JM, McCauley RL, Abdullah KM, Rutan RL, Waymack JP, Robson MC, Herndon DN. Lack of long term durability of cultured keratinocyte burn wound coverage: a case report. J Burn Care Rehabil. 1991;12:540-545.

    Not in our library10.1097/00004630-199111000-00009

Cited by papers we hold 4

• Recent advances in molecular mechanisms of skin wound healing and its treatments · 2024
  No notice
• Regenerative Medicine and Angiogenesis; Challenges and Opportunities · 2020
  Not checked
• Skin Wound Healing Process and New Emerging Technologies for Skin Wound Care and Regeneration · 2020
  No notice
• Human acellular amniotic membrane implantation for lower third nasal reconstruction: a promising therapy to promote wound healing · 2018
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.